David A. Siegel Cognition Therapeutics Inc Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 11,000 shares of CGTX stock, worth $9,240. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,000Holding current value
$9,240% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding CGTX
# of Institutions
45Shares Held
6.58MCall Options Held
0Put Options Held
0-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$1.85 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$1.04 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$420,0000.0% of portfolio
-
Geode Capital Management, LLC Boston, MA324KShares$271,8600.0% of portfolio
-
Cm Management, LLC250KShares$210,0000.1% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $19.1M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...